Subsea deoxygenation in a water injection process plant

Patent metadata

Field	Value
Publication number	US-10370272-B2
Application number	US-201615058923-A
Country	US
Kind code	B2
Filing date	Mar 2, 2016
Priority date	Mar 2, 2016
Publication date	Aug 6, 2019
Grant date	Aug 6, 2019

Abstract

A water injection process plant includes a catalytic deoxygenation unit located subsea that makes use of a reducing agent sent from topsides in liquid form. The catalyst is preferably a palladium catalyst or its equivalent. The reducing agent is an oxygen scavenger such as but not limited to hydrazine, carbohydrazide, sodium erythorbate, methyl ethyl ketoxime (“MEKO”), hydroquinone, diethylhydroxylamine (“DEHA”), formic acid (methanoic acid). A chemical umbilical can be used to deliver the reducing agent to a mixer located upstream of the deoxygenation unit, where the agent is mixed with seawater containing oxygen.

First claim

What is claimed:

1. A deoxygenation system comprising:
a catalytic deoxygenation unit located subsea; and
a reducing agent in liquid form located topsides;
the catalytic deoxygenation unit configured to operate at subsea ambient pressure and receive a mixture of a seawater stream containing, oxygen and the reducing agent.

2. A deoxygenation system according to claim 1 wherein the reducing agent is selected from the group consisting of hydrazine, carbohydrazide, sodium erythorbate, methyl ethyl keloxime, hydroquinone, diethylhydroxylamine, and formic acid.

3. A deoxygenation system according to claim 1 further comprising a chemical umbilical arranged to deliver the reducing agent subsea from a topsides source.

4. A deoxygenation system according to claim 1 further comprising a mixer located subsea ahead of the catalytic deoxygenation unit and arranged to receive the seawater stream and the reducing agent.

5. A deoxygenation system according to claim 1 further comprising a filtration system located subsea and arranged to receive the seawater stream.

6. A deoxygenation system according to claim 5 wherein the filtration system includes one or more selectively permeable membranes.

7. A deoxygenation system according to claim 6 wherein the one or more selectively permeable membranes includes a membrane selected from the group consisting of microfiltration, ultrafiltration, nanofiltration, and reverse osmosis.

8. A deoxygenation system according to claim 6 wherein at least one of the one or more selectively permeable membranes is located downstream of the catalytic deoxygenation unit.

9. A deoxygenation system according to claim 1 further comprising a strainer located subsea upstream of the catalytic deoxygenation unit.

10. A deoxygenation system according to claim 1 , the reducing agent being hydrazine.

11. A deoxygenation system according to claim 1 , the catalytic deoxygenation unit containing a palladium catalyst.

12. A method to deoxygenate a seawater stream subsea, the method comprising:
delivering from topsides to subsea a reducing, agent in liquid form;
mixing the reducing agent with a seawater stream containing oxygen; and
deoxygenating a mixture of the reducing agent and the seawater stream subsea by reacting the reducing agent with the oxygen in the presence of a catalyst in a catalytic deoxygenation unit located subsea;

wherein the catalytic deoxygenation unit is configured to operate at subsea ambient pressure.

13. A method according to claim 12 wherein the reducing agent is selected from the group consisting of hydrazine, carbohydrazide, sodium erythorbate, methyl ethyl ketoxime, hydroquinone, diethylhydroxylamine, and formic acid.

14. A method according to claim 12 further comprising filtering the seawater stream using one or more selectively permeable membranes.

15. A method according to claim 14 wherein the one or more selectively permeable membranes includes a membrane selected from the group consisting of microfiltration, ultrafiltration, nanofiltration, and reverse osmosis.

16. A method according to claim 14 wherein at least one of the one or more selectively permeable membranes is located downstream of the catalytic deoxygenation unit.

17. A method according to claim 12 , the reducing agent being hydrazine.

18. A method according to claim 12 , the catalytic deoxygenation unit containing a palladium catalyst.

19. A biofouling control, deoxygenation and filtration system comprising:
a biofouling control unit located subsea, the biofouling control unit including chemical dosing means;
a deoxygenation system comprising a catalytic deoxygenation unit located subsea and configured to operate at subsea ambient pressure and receive a seawater stream containing oxygen and a liquid reducing agent, the catalytic deoxygenation unit located downstream of the biofouling control unit and including a palladium catalyst;
a liquid reducing agent source located topsides, the liquid reducing agent being selected from the group consisting of hydrazine, carbohydrazide, sodium erythorbate, methyl ethyl ketoxime, hydroquinone, diethylhydroxylamine, and formic acid;
a chemical umbilical connected to the liquid reducing agent source and the catalytic deoxygenation unit and configured to deliver the liquid reducing agent from the liquid reducing agent source located topsides to the catalytic deoxygenation unit located subsea; and
a filtration system located subsea and including selectively permeable membrane means configured to receive a stream exiting one of the biofouling control unit or the catalytic deoxygenation unit.

Assignees

• Cameron Solutions Inc

Inventors

• Knox-Holmes Brent

Classifications

• C02F1/70 Primary

  by reduction {(C02F1/4676 takes precedence)} · CPC title

• C02F1/725

  by catalytic oxidation · CPC title

• C02F1/4674

  with halogen or compound of halogens, e.g. chlorine, bromine · CPC title

• B01D61/145

  Ultrafiltration · CPC title

• B01D19/0005

  with one or more auxiliary substances · CPC title